GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » Current Deferred Revenue

Alterola Biotech (Alterola Biotech) Current Deferred Revenue : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Alterola Biotech Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Alterola Biotech's current deferred revenue for the quarter that ended in Dec. 2023 was $0.00 Mil.

Alterola Biotech Current Deferred Revenue Historical Data

The historical data trend for Alterola Biotech's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech Current Deferred Revenue Chart

Alterola Biotech Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Mar22 Mar23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alterola Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alterola Biotech Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Alterola Biotech's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Alterola Biotech (Alterola Biotech) Business Description

Traded in Other Exchanges
N/A
Address
47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR
Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.
Executives
Bright Green Corp 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301